[Insulin secretion in the clinical stages of diabetes (with glucose tolerance test abnormalities)].
D001786:Blood Glucose / Q000378:metabolism; D003920:Diabetes Mellitus / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism*; D005947:Glucose / Q000494:pharmacology; D005951:Glucose Tolerance Test; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D007333:Insulin Resistance; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D009765:Obesity; D012636:Secretory Rate / Q000187:drug effects; D014044:Tolbutamide / Q000494:pharmacology
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D014044:Tolbutamide; D005947:Glucose
L'insulino-sécrétion dans le diabète a ses phases cliniques (tolérance du glucose perturbée)